Danish pharmaceutical executive
According to Wikipedia, Flemming Ørnskov is a Danish businessman. He has been the chief executive officer of Galderma since October 2019. He was previously the CEO of Shire plc, a FTSE 100 specialty biopharmaceutical company as of 30 April 2013, succeeding Angus Russel. He previously worked for Bayer, Bausch & Lomb and Novartis.
Flemming Ørnskov is affiliated with the following schools: